Valuation: Virbac

Market Cap 2.78B 3.18B 2.55B 2.38B 4.52B 303B 4.58B 30.7B 11.92B 149B 11.94B 11.68B 513B P/E 2026 *
16.5x
P/E 2027 * 14.7x
Enterprise Value 2.9B 3.32B 2.67B 2.49B 4.71B 316B 4.78B 32.04B 12.44B 155B 12.46B 12.19B 536B EV / Sales 2026 *
1.88x
EV / Sales 2027 * 1.71x
Free-Float
49.03%
Yield 2026 *
0.53%
Yield 2027 * 0.62%
1 day+0.15%
1 week-3.07%
Current month-0.15%
1 month-3.77%
3 months-5.41%
6 months-6.08%
Current year-7.13%
1 week 327.5
Extreme 327.5
347
1 month 327.5
Extreme 327.5
359
Current year 326.5
Extreme 326.5
389.5
1 year 296
Extreme 296
389.5
3 years 232.5
Extreme 232.5
400
5 years 215
Extreme 215
448.5
10 years 102.1
Extreme 102.1
448.5
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Date Insider Type Main position Quantity % Market Cap.
22/04/24Sell

Chief Executive Officer

810 0.0096%
22/04/24Sell

Chief Executive Officer

140 0.0017%
22/04/24Sell

Chief Executive Officer

370 0.0044%
Change 5-day change 1-year change 3-year change Capi.($)
+0.15%-3.07%+5.06%+22.74% 3.18B
+3.24%-3.88%-52.98%-56.56% 31.36B
+3.78%+2.59%+69.84%+148.51% 12.49B
+1.56%-6.31%-13.31%+6.27% 3.78B
+2.93%+1.90%+54.45%+29.44% 1.92B
+0.50%+0.50%-26.13%+18.36% 1.65B
+3.61%+4.49%+19.04%+142.77% 1.35B
+2.74%+6.14%-19.74%-11.63% 1.02B
-1.39%-1.53%-3.67%-22.54% 955M
+2.29%+3.82%-14.97%-46.49% 919M
Average +1.94%+1.91%+1.76%+23.09% 5.86B
Weighted average by Cap. +2.90%-0.90%-13.20%+6.48%

Financials

2026 *2027 *
Net sales 1.55B 1.77B 1.42B 1.32B 2.51B 168B 2.55B 17.07B 6.63B 82.73B 6.64B 6.49B 285B 1.64B 1.87B 1.51B 1.4B 2.66B 179B 2.7B 18.1B 7.03B 87.72B 7.04B 6.89B 303B
Net income 167M 191M 153M 143M 271M 18.19B 275M 1.84B 716M 8.94B 717M 701M 30.82B 190M 217M 175M 163M 309M 20.71B 313M 2.1B 815M 10.18B 817M 799M 35.1B
Net Debt 121M 138M 111M 104M 196M 13.18B 199M 1.34B 519M 6.47B 519M 508M 22.33B 26.49M 30.29M 24.33M 22.69M 43.01M 2.89B 43.64M 292M 114M 1.42B 114M 111M 4.89B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
03/07/26 €332.00 +0.15% 3,366
02/07/26 €331.50 +0.45% 6,240
01/07/26 €330.00 -0.75% 5,366
30/06/26 €332.50 -1.92% 6,550
29/06/26 €339.00 -0.88% 3,278
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
332.00EUR
Average target price
412.88EUR
Spread / Average Target
+24.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIRP Stock